Joseph C. Wu

Back to Profile

Publication Details

  • 18F-labeled bombesin analogs for targeting GRP receptor-expressing prostate cancer.

    Zhang X, Cai W, Cao F, Schreibmann E, Wu Y, Wu JC, Xing L, Chen X. J Nucl Med. 2006; 47 (3): 492-501

    The gastrin-releasing peptide receptor (GRPR) is found to be overexpressed in a variety of human tumors. The aim of this study was to develop 18F-labeled bombesin analogs for PET of GRPR expression in prostate cancer xenograft models.

    PubMedID: 16513619

Stanford Medicine Resources:

Footer Links: